Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients

Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients

Abstract Background Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive and irreversible respiratory failure. Non-invasive markers of disease activity are essential for prognosis and evaluation of early response to anti-fibrotic treatments. Objectives The aims of this study were to...

Full description

Bibliographic Details
Main Authors: Benjamin Bondue, Amélie Castiaux, Gaetan Van Simaeys, Céline Mathey, Félicie Sherer, Dominique Egrise, Simon Lacroix, François Huaux, Gilles Doumont, Serge Goldman
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Respiratory Research
Subjects:
Idiopathic pulmonary fibrosis
IPF
PET/CT
Biomarker
Interstitial lung disease
ILD
Online Access:http://link.springer.com/article/10.1186/s12931-019-0974-5

Internet

http://link.springer.com/article/10.1186/s12931-019-0974-5

Similar Items